Renato Colognato

Research And Development Manager at Nippon Gases Italia
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Milan, Lombardy, Italy, IT

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Italy
    • Chemical Manufacturing
    • 200 - 300 Employee
    • Research And Development Manager
      • Jan 2023 - Present

      Milano, Lombardia, Italia

    • Scientific Advisor
      • Mar 2021 - Mar 2023

    • Italy
    • Personal Care Product Manufacturing
    • 1 - 100 Employee
    • Chief Scientific Officer
      • Jun 2018 - Sep 2021

      Verbania, Piemonte, Italia - Responsible for the R&D Unit in the implementation of the ANALYSIS PORTFOLIO upon client request. - Development of International (European Commission) and National research proposals - Implemented Marketing strategies

    • Italy
    • Medical Equipment Manufacturing
    • 1 - 100 Employee
    • R&D Manager
      • Jan 2016 - Dec 2018

      Lesa, Piemonte, Italia - Responsible for the R&D Unit and the QA Unit in the implementation of different class of Medical Devices (I, IIa, and IIB) (MD). The experience in MOSS brought to the commercialisation of MD in Europe with the brand name NOVOX and in the United States with the brand CUROXEN - During the MOSS experience we successfully passed the FDA 510k verification

    • Founder & Scientific Director
      • Jul 2014 - Jan 2018

      Insubria's Biopark INNOVITAS VITAE (i-vitae) is a biotech startup company in compliance with the Italian Act 221/12, that truly certifies and qualifies its innovating DNA. It was founded as a spin-out of a biotech company, named GeXNano (same founders!), which developed 3 patent applications in the field of Reproductive Medicine, exclusively licensed to his "daughter". I-VITAE holds a unique and distinctive knowledge and expertise that allow our company to enter and penetrate the market with validated… Show more INNOVITAS VITAE (i-vitae) is a biotech startup company in compliance with the Italian Act 221/12, that truly certifies and qualifies its innovating DNA. It was founded as a spin-out of a biotech company, named GeXNano (same founders!), which developed 3 patent applications in the field of Reproductive Medicine, exclusively licensed to his "daughter". I-VITAE holds a unique and distinctive knowledge and expertise that allow our company to enter and penetrate the market with validated diagnostic methods & panels able to accurately detect and determine female infertility accurately, that are based on new biomarkers. I-vitae has also been developing new food supplements to cure specific kinds of female infertility. I-vitae will be keeping on researching and developing disruptive services and products using Open Innovation approaches and models. Show less

    • Founder & President
      • Apr 2011 - Mar 2014

      Insubria's Biopark (Gerenzano) and OXI.GEN Lab. (Brescia) GeXNano is a Biotech Start-Up dealing with experimental in vitro and in vivo NANOtoxicological screening (basal cytotoxicity, immunotoxicity, genotoxicity, cancerogenity and mutagenicity). Together with nanotoxicological screening service, GeXNano is also working in the development and implementation of nanomaterials-based medical devices, for diagnosis and therapeutical purposes for biomedical sciences in different clinical fields like assisted reproduction, oncology and neurology mainly… Show more GeXNano is a Biotech Start-Up dealing with experimental in vitro and in vivo NANOtoxicological screening (basal cytotoxicity, immunotoxicity, genotoxicity, cancerogenity and mutagenicity). Together with nanotoxicological screening service, GeXNano is also working in the development and implementation of nanomaterials-based medical devices, for diagnosis and therapeutical purposes for biomedical sciences in different clinical fields like assisted reproduction, oncology and neurology mainly for neurodegenerative diseases. GeXNano has been officially established in April 2012 and the Laboratory facility is settled within the Insubria's Biopark. Since March 2014 been approved by the Servizio Sanitario Regionale as Servizio di Medicina di Laboratorio (S.ME.L) with the Clinical Biochemistey Section for laboratory diagnosis. Show less

    • Pharmacogenetic Unit
      • Jan 2011 - Mar 2012

    • United States
    • Biotechnology
    • 1 - 100 Employee
    • R&D Manager
      • May 2009 - Dec 2010

    • Contactual Agent
      • Aug 2007 - May 2009

Education

  • Università di Pisa
    Master of Science, Applied Genetics
    2003 - 2006
  • Clinical University of Ulm (Germany)
    PhD, Clinical Pharmacology
    1999 - 2003
  • Università di Pisa
    BS, Biological Sciences
    1992 - 1998

Community

You need to have a working account to view this content. Click here to join now